This book analyzes the post-subprime crisis world from the global, Asian and Chinese perspectives. It dispels some of the myths about the crisis's effects on Asia and China; and exposes the ugly truth of bailout policies and their distortion and hindering of the world's economic rebalancing effort in the post-subprime era.

Conventional analytical tool kits often do not work in China due to its strong idiosyncrasies and opaque system. Using rigorous economic analysis, backed by solid data and accounts of real life experiences, this book twists conventional wisdom to drive the thinking about China 'outside the box'. Many books on China are long on volume but short on thoughts. This book is the opposite. It dispels China's economic myths and probes deep into the hidden forces that drive China's economic future.

Until recently the world has been relying on the US dollar and the Euro to lubricate the flow of global trade and finance. A newcomer, the Renminbi (RMB) or Chinese Yuan, joined the global monetary system in 2000. The rise of the RMB is both an indicator and a result of the evolution in the global macro landscape that shifts economic weight from the developed markets, led by Europe, Japan and the US, to the emerging markets, led by China.Research on RMB internationalisation is difficult because events have been unfolding fast, with frequent shifting regulations. Most financial market research is sales-driven, shallow and without serious investigation into the structural underpinning of events. Most crucially, there has been insufficient systematic research on the structural realities behind the RMB internationalisation exercise. No-one has openly questioned the credibility of the RMB as an international currency. This is the first book to address these issues by focusing on the structural factors behind the rise of the RMB. It uses a critical approach, questioning conventional wisdom and the status quo to anslyse China's currency ambition in the post-subprime world. Discussions combine rigorous research thoughts, data, facts and economic logic with real world issues to elaborate on the arguments and make them reader-friendly.

This book compares the policy approaches taken by China and India in dealing with HIV/AIDS, illuminating the challenges they face as they grapple with this intractable disease and identifying best practices for dealing with HIV/AIDS in the developing world and beyond.

This is the first book to put together Asia and the developed world in the subprime crisis context and to combine macro and micro analysis to draw lessons from it. The crisis has valuable lessons for the dergulation of China's insurance industry, which is seen as the 'goldmine' in the future of global financial development.

Veganism is so much more than what we eat. It's about striving to live an ethical life in a profoundly unethical world. Is being vegan difficult or is it now easier than ever? What does veganism have to do with wider struggles for social justice - feminism, LGBTQ+ politics, anti-racism and environmentalism?

In 1993, the genetic mutation responsible for Huntington's disease (HD) was identified. Considered a milestone in human genomics, this discovery has led to nearly two decades of remarkable progress that has greatly increased our knowledge of HD, and documented an unexpectedly large and diverse range of biochemical and genetic perturbations that seem to result directly from the expression of the mutant huntingtin gene. Neurobiology of Huntington's Disease: Applications to Drug Discovery presents a thorough review of the issues surrounding drug discovery and development for the treatment of this paradigmatic neurodegenerative disease. Drawing on the expertise of key researchers in the field, the book discusses the basic neurobiology of Huntington's disease and how its monogenic nature confers enormous practical advantages for translational research, including the creation of robust experimental tools, models, and assays to facilitate discovery and validation of molecular targets and drug candidates for HD. Written to support future basic research as well as drug development efforts, this volume: Covers the latest research approaches in genetics, genomics, and proteomics, including high-throughput and high-content screening Highlights advances in the discovery and development of new drug therapies for neurodegenerative disorders Examines the practical realities of preclinical testing, clinical testing strategies, and, ultimately, clinical usage While the development of effective drug treatments for Huntington's disease continues to be tremendously challenging, a highly interactive and cooperative community of researchers and clinical investigators now brings us to the threshold of potential breakthroughs in the quest for therapeutic agents. The impressive array of drug discovery resources outlined in the text holds much promise for treating this devastating disease, providing hope to long-suffering Huntington's disease patients and their families.

This book breaks new ground in research on the RMB's offshore market by addressing the myths, hypes and realities surrounding the rise of the Chinese Yuan. It is the first book to address the rise of the Renminbi by focusing on the structural factors behind it and drawing on the global, regional and domestic developments affecting its development.

This book analyzes the post-subprime crisis world from the global, Asian and Chinese perspectives. It dispels some of the myths about the crisis's effects on Asia and China; and exposes the ugly truth of bailout policies and their distortion and hindering of the world's economic rebalancing effort in the post-subprime era.

Using rigorous economic analysis backed by solid data and accounts of real life experiences, this book twists conventional wisdom to drive the thinking about China 'outside the box'. It dispels China's economic myths and probes deep into the hidden forces that drive China's economic future.

This is the first book to put together Asia and the developed world in the subprime crisis context and to combine macro and micro analysis to draw lessons from it. The crisis has valuable lessons for the dergulation of China's insurance industry, which is seen as the 'goldmine' in the future of global financial development.

This fascinating collection of recipes contributed by the members of the Ladies' Aid Society of the Fort Street Methodist Episcopal Church of Los Angeles, California, originally published in 1881, includes such familiar dishes as fish chowder, roast turkey, and chocolate cake. More unusual offerings include stewed pigeons, suet pudding, and English brawn, made with a pig's head. Interspersed throughout the book are historic and charming advertisements from Los Angeles businesses - purveyors of stove polish, gents' furnishing goods, and ladies' ready-made dresses among them.

This is an easy read book written to take your mind off all the stress in your busy work day. It will leave you laughing at everyday normal things you see as you go through live and wonder about. And you thought you were the only one who had those thoughts

In 1993, the genetic mutation responsible for Huntington's disease (HD) was identified. Considered a milestone in human genomics, this discovery has led to nearly two decades of remarkable progress that has greatly increased our knowledge of HD, and documented an unexpectedly large and diverse range of biochemical and genetic perturbations that seem to result directly from the expression of the mutant huntingtin gene. Neurobiology of Huntington's Disease: Applications to Drug Discovery presents a thorough review of the issues surrounding drug discovery and development for the treatment of this paradigmatic neurodegenerative disease. Drawing on the expertise of key researchers in the field, the book discusses the basic neurobiology of Huntington's disease and how its monogenic nature confers enormous practical advantages for translational research, including the creation of robust experimental tools, models, and assays to facilitate discovery and validation of molecular targets and drug candidates for HD. Written to support future basic research as well as drug development efforts, this volume: Covers the latest research approaches in genetics, genomics, and proteomics, including high-throughput and high-content screening Highlights advances in the discovery and development of new drug therapies for neurodegenerative disorders Examines the practical realities of preclinical testing, clinical testing strategies, and, ultimately, clinical usage While the development of effective drug treatments for Huntington's disease continues to be tremendously challenging, a highly interactive and cooperative community of researchers and clinical investigators now brings us to the threshold of potential breakthroughs in the quest for therapeutic agents. The impressive array of drug discovery resources outlined in the text holds much promise for treating this devastating disease, providing hope to long-suffering Huntington's disease patients and their families.